Mailing Address:
Harvard Medical School
Department of Population Medicine
133 Brookline Avenue, 6th Floor
Boston, MA 02215
Larissa_Nekhlyudov@harvardpilgrim.org
Phone: (617) 509-9983
Fax: (617) 859-8112
Staff Assistant: Jane Colagiovanni
Clinical Affiliations: HVMA
Dana-Farber/Harvard Cancer Center,
Cancer Programs at DACP
|
Larissa Nekhlyudov, MD, MPH
Dr. Nekhlyudov is an Assistant Professor in the Department of Population Medicine at Harvard Medical School and a general internist at Harvard Vanguard Medical Associates. Her research spans across the spectrum of breast cancer and aims to improve women's decision making and quality of life. She is particularly interested in improving the care of cancer survivors and the interplay between primary care and oncology care. Dr. Nekhlyudov has published numerous original manuscripts in leading cancer and general medicine journals. She has obtained funding from the Centers for Disease Control and Prevention and the National Cancer Institute. Dr. Nekhlyudov has a number of local and national leadership roles. She currently serves as the Director of Cancer Research in the Department of Population Medicine, Director of the National Cancer Institute-funded Community Practice Core at the Dana-Farber/Harvard Cancer Center, and Associate Site Director in the National Cancer Institute-funded HMO Cancer Research Network. She is on the Advisory Board of the Massachusetts Cancer Registry. Dr. Nekhlyudov teaches at Harvard Medical School, and in 2007 received the Society of General Internal Medicine Junior Faculty Education Award.
Selected Publications:
Nekhlyudov L,Habel LA,Achacoso NS,Jung I,Haque R,Collins LC,Schnitt SJ,Quesenberry CP,Fletcher SW,.
Adherence to Long-Term Surveillance Mammography Among Women With Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery
.
J Clin Oncol. 2009 Jul 1;19:3211-3216
Nekhlyudov L,.
'Doc, should I see you or my oncologist?': a primary care perspective on opportunities and challenges in providing comprehensive care for cancer survivors
.
J Clin Oncol. 2009 May 20;15:2424-2426
Nekhlyudov L,Kiarsis K,Elmore JG,.
MRI of the breast: does the internet accurately report its beneficial uses and limitations?
.
Breast J. 2009 Mar;2:189-193
Nekhlyudov L,Li R,Fletcher SW,.
Informed decision making before initiating screening mammography: does it occur and does it make a difference?
.
Health Expect. 2008 Dec;4:366-375
Nekhlyudov L,Kroenke CH,Jung I,Holmes MD,Colditz GA,.
Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study
.
J Clin Oncol. 2006 Jun 20;18:2822-2827
Nekhlyudov L,Li R,Fletcher SW,.
Information and involvement preferences of women in their 40s before their first screening mammogram
.
Arch Intern Med. 2005 Jun 27;12:1370-1374
Nekhlyudov L,Bower M,Herrinton LJ,Altschuler A,Greene SM,Rolnick S,Elmore JG,Harris EL,Liu A,Emmons KM,Fletcher SW,Geiger AM,.
Women's decision-making roles regarding contralateral prophylactic mastectomy
.
J Natl Cancer Inst Monogr. 2005;35:55-60
Nekhlyudov L,Partridge A,.
Breast cancer risk communication: challenges and future research directions: workshop report (United States)
.
Cancer Causes Control. 2003 Apr;3:235-239
Nekhlyudov L,Ross-Degnan D,Fletcher SW,.
Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study
.
J Gen Intern Med. 2003 Mar;3:182-189
Nekhlyudov L,Barton MB,Elmore JG,Fletcher SW,.
Breast self-examination: who teaches it, who is taught, and how often? (United States)
.
Cancer Causes Control. 2002 May;4:343-351
|
